Bergapten is under investigation in clinical trial NCT00533195 (Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis).
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Porfimer sodium | Bergapten may increase the photosensitizing activities of Porfimer sodium. |
| Verteporfin | Bergapten may increase the photosensitizing activities of Verteporfin. |
| Dexmethylphenidate | The serum concentration of the active metabolites of Bergapten can be increased when Bergapten is used in combination with Dexmethylphenidate. |
| Glimepiride | The therapeutic efficacy of Glimepiride can be increased when used in combination with Bergapten. |
| Acetohexamide | The therapeutic efficacy of Acetohexamide can be increased when used in combination with Bergapten. |
| Chlorpropamide | The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Bergapten. |
| Tolazamide | The therapeutic efficacy of Tolazamide can be increased when used in combination with Bergapten. |
| Glyburide | The therapeutic efficacy of Glyburide can be increased when used in combination with Bergapten. |
| Glipizide | The therapeutic efficacy of Glipizide can be increased when used in combination with Bergapten. |
| Gliclazide | The therapeutic efficacy of Gliclazide can be increased when used in combination with Bergapten. |
| Tolbutamide | The therapeutic efficacy of Tolbutamide can be increased when used in combination with Bergapten. |
| Gliquidone | The therapeutic efficacy of Gliquidone can be increased when used in combination with Bergapten. |
| Glisoxepide | The therapeutic efficacy of Glisoxepide can be increased when used in combination with Bergapten. |
| Glibornuride | The therapeutic efficacy of Glibornuride can be increased when used in combination with Bergapten. |
| Carbutamide | The therapeutic efficacy of Carbutamide can be increased when used in combination with Bergapten. |
| Metahexamide | The therapeutic efficacy of Metahexamide can be increased when used in combination with Bergapten. |
| Tretinoin | The risk or severity of adverse effects can be increased when Tretinoin is combined with Bergapten. |
| Padeliporfin | Bergapten may increase the photosensitizing activities of Padeliporfin. |
| Lepirudin | The risk or severity of bleeding can be increased when Bergapten is combined with Lepirudin. |
| Doxycycline | The therapeutic efficacy of Bergapten can be increased when used in combination with Doxycycline. |
| Diazoxide | The serum concentration of Bergapten can be increased when it is combined with Diazoxide. |